Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 18/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 18/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 18/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 18/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 9/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 9/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9263999 | 0.78 | AXL (0.48) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL8945427 | 0.71 | HTT (0.74) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL9260020 | 0.70 | MAPT (0.53) | HTT | |
| SCHEMBL2878014 | 0.67 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL9258621 | 0.67 | GRIN1 (0.36) | — | |
| SCHEMBL9259301 | 0.67 | ALDH1A1 (0.48) | HTT | |
| Hydrochloric Acid SCHEMBL5642444 | 0.66 | PDE4A (0.54) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL9265990 | 0.66 | LMNA (0.41) | HTT | |
| SCHEMBL12619546 | 0.66 | PDE4B (0.59) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL9269176 | 0.66 | MAPT (0.39) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5387585-A | Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia | HOFFMANN-LA ROCHE INC. (US) | 1995-02-07 | — | — | US | disclosed |
| EP-0519307-A2 | Tetracyclic Imidazodiazepines | F. HOFFMANN-LA ROCHE AG (CH) | 1992-12-23 | — | — | EP | disclosed |